Valuation (47%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 51.26 | 12.76 |
PEG Ratio (TTM) | 4.75 | 0.89 |
P/S Ratio (TTM) | 2.10 | 2.55 |
P/B Ratio (TTM) | 1.11 | 1.71 |
P/FCF Ratio (TTM) | 8.21 | 9.91 |
Price to 5YR AVG Earnings Ratio | -60.73 | 13.66 |
Price to 5YR AVG FCF Ratio | 8.13 | 7.55 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.18% | 9.40% |
ROE (TTM) | 2.20% | 9.27% |
Net Profit Margin (TTM) | 4.04% | 16.06% |
ROIC 5YR AVG | 2.86% | 19.82% |
Growth (28%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -299.76% | -170.70% | -109.71% |
Revenue | 14.97% | -6.43% | 7.74% |
Net Income | -300.89% | -170.45% | -111.63% |
Cash Flow | 57.21% | 0.21% | 8.66% |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.16 | 2.84 |
Quick Ratio (TTM) | 0.16 | 4.31 |
D/E Ratio (TTM) | 0.81 | 1.35 |
Interest Coverage (TTM) | 0.19 | 0.70 |
Piotroski F-Score | 7 | 6 |
Altman Z-Score | N/A | 0.30 |
LTL to 5YR AVG FCF | 1.76 | 6.38 |
Shares Outstanding Growth 5YR AVG | -1.09% | 5.13% |